First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

计划入组 9 人 · 首次发布于 2026 年 5 月 1 日

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

计划入组 36 人 · 首次发布于 2025 年 12 月 24 日

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

计划入组 92 人 · 首次发布于 2003 年 6 月 10 日

FLAMOD

Stimulan-VG

Escozine

Xi'an No.4 Hospital

China

Guiyang No.4 People's Hospital

China

Huai'an No.4 People's Hospital

China

ClearPoint Neuro's MR-Guided Laser Therapy Shows Promise for Brain Cancer Treatment in Phase I-II Study

MR-Linac Adaptive Radiotherapy Reduces Radiation Exposure in High-Grade Glioma

Eflornithine Plus Lomustine Improves Survival in IDH-Mutant Grade 3 Astrocytoma